Cas:202865-58-5 1-Bromo-4,5-difluoro-2-methoxybenzene manufacturer & supplier

Chemical Name:1-Bromo-4,5-difluoro-2-methoxybenzene

CAS.NO:202865-58-5

Synonyms:MFCD00070753;2-Bromo-4,5-difluoroanisole;1-Bromo-4,5-difluoro-2-methoxybenzene;4-bromo-1,2-difluoro-5-methoxybenzene;2-Bromo-4,5-difluorophenyl methyl ether;Benzene, 1-bromo-4,5-difluoro-2-methoxy-

Molecular Formula:C₇H₅BrF₂O

Molecular Weight:223.015

HS Code:2909309090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:200.6±35.0 °C at 760 mmHg

Density:1.6±0.1 g/cm3

Index of Refraction:1.500

PSA:9.23000

Exact Mass:221.949173

LogP:2.77

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like MFCD00070753 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzene, 1-bromo-4,5-difluoro-2-methoxy- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Bromo-4,5-difluoro-2-methoxybenzene Use and application,1-Bromo-4,5-difluoro-2-methoxybenzene technical grade,usp/ep/jp grade.

Related News: Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday. 1-Bromo-4,5-difluoro-2-methoxybenzene manufacturer Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday. 1-Bromo-4,5-difluoro-2-methoxybenzene supplier All of China��s provinces and territories have now been touched by the outbreak. 1-Bromo-4,5-difluoro-2-methoxybenzene vendor Darzalex does have another regimen approved for the same myeloma population. Darzalex combined with Takeda’s Velcade, melphalan and prednisone (VMP) reduced the risk of death by 40% in the phase 3 ALCYONE trial. But disease progression had already occurred in half of patients on the Darzalex-VMP combo after about three years of follow-up, a much shorter period than the five-year mark the Darzalex-Rd regimen is approaching. 1-Bromo-4,5-difluoro-2-methoxybenzene factory We have leading expertise in strategy and operational implementation of pre-approval access programs making pharmaceutical products under clinical development available for patients and Inceptua��s clinical trial services business offers high quality clinical comparator sourcing and manufacturing services with an agile global supply chain to ensure that products are delivered exactly when needed.